UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The clinical trail of TRAIL

European journal of cancer (1990), 2006-09, Vol.42 (14), p.2233-2240

2006

Volltextzugriff (PDF)

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands

Breast cancer research and treatment, 2011-08, Vol.129 (1), p.229-233

2011

Volltextzugriff (PDF)

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study

Annals of oncology, 2012-11, Vol.23 (11), p.2896-2902

2012

Volltextzugriff (PDF)

Intraperitoneal cisplatin versus no further treatment: 8‐year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum‐based intravenous chemotherapy

International journal of gynecological cancer, 2003-11, Vol.13 (s2), p.196-203

2003

Volltextzugriff (PDF)

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.622-633

2007

Volltextzugriff (PDF)

Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer

European Journal of Cancer, 2009-05, Vol.45 (7), p.1193-1200

2009

Volltextzugriff (PDF)

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

British journal of cancer, 2002-05, Vol.86 (10), p.1546-1550

2002

Volltextzugriff (PDF)

Prognostic factors of long-term functioning and productivity after traumatic brain injury: a systematic review of prospective cohort studies

Clinical Rehabilitation, 2007-11, Vol.21 (11), p.1024-1037

2007

Volltextzugriff (PDF)

Effects of Recombinant Human Interleukin-6 in Cancer Patients: A Phase I-II Study

Blood, 1994-09, Vol.84 (5), p.1434-1441

1994

Volltextzugriff (PDF)

Severe disabling tendinopathy caused by anastrazole

Rheumatology (Oxford, England), 2007-10, Vol.46 (10), p.1619-1621

2007

Volltextzugriff (PDF)

Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort

Gynecologic oncology, 2007-05, Vol.105 (2), p.365-372

2007

Volltextzugriff (PDF)

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

Journal of clinical oncology, 1995-01, Vol.13 (1), p.70-78

1995

Volltextzugriff (PDF)

Ovarian cysts in women receiving tamoxifen for breast cancer

British Journal of Cancer, 1999-04, Vol.79 (11-12), p.1761-1764

1999

Volltextzugriff (PDF)

Neuropsychological investigation into the carcinoid syndrome

Psychopharmacologia, 2003-07, Vol.168 (3), p.324-328

2003

Volltextzugriff (PDF)

Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer

Cancer treatment reviews, 2003-12, Vol.29 (6), p.471-488

2003

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin

British journal of cancer, 1999-02, Vol.79 (5-6), p.882-887

1999

Volltextzugriff (PDF)

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium

Journal of clinical pathology, 2002-07, Vol.55 (7), p.514-519

2002

Volltextzugriff (PDF)

Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis

Journal of clinical oncology, 1992-07, Vol.10 (7), p.1119-1123

1992

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of intraperitoneal topotecan

British journal of cancer, 2001-11, Vol.85 (11), p.1627-1633

2001

Volltextzugriff (PDF)

Drug Resistance-associated Markers P-Glycoprotein, Multidrug Resistance-associated Protein 1, Multidrug Resistance-associated Protein 2, and Lung Resistance Protein as Prognostic Factors in Ovarian Carcinoma

Clinical cancer research, 1999-10, Vol.5 (10), p.2798-2805

1999

Volltextzugriff (PDF)

Heat‐shock‐protein‐27(HSP27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis

International journal of cancer, 1999-06, Vol.84 (3), p.234-238

1999

Volltextzugriff (PDF)

Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

Gynecologic oncology, 2000-07, Vol.78 (1), p.16-20

2000

Volltextzugriff (PDF)

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer

British journal of cancer, 1995-06, Vol.71 (6), p.1302-1307

1995

Volltextzugriff (PDF)

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer

Journal of clinical oncology, 1995-10, Vol.13 (10), p.2585-2593

1995

Volltextzugriff (PDF)

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

British journal of cancer, 2005-09, Vol.93 (5), p.520-528

2005

Volltextzugriff (PDF)

1 – 25 von 484

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(413)
Mit Volltextzugriff
(380)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(321)
Humans
(300)
Life Sciences & Biomedicine
(294)
Female
(220)
Biological And Medical Sciences
(197)
Medical Sciences
(180)
Middle Aged
(160)
Oncology
(152)
Adult
(151)
Male
(121)
Aged
(111)
Pharmacology. Drug Treatments
(105)
Antineoplastic Agents
(75)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(72)
Chemotherapy
(70)
Ovarian Neoplasms - Drug Therapy
(46)
Tumors
(44)
Breast Neoplasms - Drug Therapy
(41)
Adolescent
(37)
Prognosis
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The clinical trail of TRAIL

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study

Intraperitoneal cisplatin versus no further treatment: 8‐year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum‐based intravenous chemotherapy

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study

Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

Prognostic factors of long-term functioning and productivity after traumatic brain injury: a systematic review of prospective cohort studies

Effects of Recombinant Human Interleukin-6 in Cancer Patients: A Phase I-II Study

Severe disabling tendinopathy caused by anastrazole

Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

Ovarian cysts in women receiving tamoxifen for breast cancer

Neuropsychological investigation into the carcinoid syndrome

Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium

Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis

A phase I and pharmacokinetic study of intraperitoneal topotecan

Drug Resistance-associated Markers P-Glycoprotein, Multidrug Resistance-associated Protein 1, Multidrug Resistance-associated Protein 2, and Lung Resistance Protein as Prognostic Factors in Ovarian Carcinoma

Heat‐shock‐protein‐27(HSP27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis

Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

Suchergebnisse filtern